Molecular Diagnosis

, Volume 8, Issue 1, pp 11–16 | Cite as

Enteroviral Infection in Greek AIDS Patients

  • Dimitrios Papaventsis
  • Panayotis MarkoulatosEmail author
  • Nikolaos Mangafas
  • Marios Lazanas
  • Stamatina Levidiotou-Stefanou
Original Research Article


Objective: Prolonged intestinal replication of polioviruses has not previously been studied in Greek AIDS patients. The objective of our study was to estimate the prevalence of enteroviral infections in this population.

Methods: Nineteen stool samples were investigated from 19 different patients. Collection took place at the Hellenic Red Cross Hospital, Athens, Greece, between August and October 2002. Samples were processed as follows: virus isolation was attempted by cell culture using three different cell lines (human epidermoid carcinoma [Hep]-2, rabdomyosarcoma [RD], and mouse cells genetically modified in order to express the polio virus receptor in their cell surface [L20b]). An enterovirus-specific reverse transcription (RT)-PCR was then applied. Finally, seroneutralization tests were performed on 11 blood samples taken from a number of the patients who had supplied stool samples.

Results: Samples were negative for enterovirus detection of any serotype on all cell lines. No cytopathic effect was observed. Enterovirus-specific RT-PCR assays were also negative for the detection of enteroviral RNA. Seroneutralization revealed relatively high antibody titers against poliovirus 1 and 2 in three of the eleven blood samples.

Conclusions: Greek AIDS patients are not vulnerable to enteroviral infections and do not constitute a potential reservoir of poliovirus-prolonged excretion in Greece.


Human Immunodeficiency Virus Aseptic Meningitis Oral Poliovirus Vaccine Enteroviral Infection Paralytic Poliomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We gratefully acknowledge Aikaterini Moustakli, nurse at the Infectious Diseases Department, Red Cross General Hospital, Athens, for her essential and precious help during sample collection and Eleni Afentaki, technologist at the Department of Virology, Hellenic Pasteur Institute, Athens, for her technical support.

This work was funded by the Délégation Génerale au Réseau International des Instituts Pasteur et Instituts assosiés (AC 99 Entérovirus & AC 02 Vaccin Polio Oral).

The authors have no conflicts of interest directly relevant to the content of this study.


  1. 1.
    Melnick JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields BN, Knipe DM, Howely PM, et al., editors. Virology. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1990: 549–605Google Scholar
  2. 2.
    The global polio eradication initiative: strategic plan 2001–2005. Geneva: Department of Vaccines & Biologicals, World Health Organization, 2000Google Scholar
  3. 3.
    Klatt E. Pathology of AIDS (version 12). Tallahassee (FL): Florida State University College of Medicine, 2002: 5Google Scholar
  4. 4.
    Fauci A, Clifford HL. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In: Fauci A, Braunwald E, Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine. 14th ed. New York: McGraw Hill, 1998: 1802–12Google Scholar
  5. 5.
    Wallach J. Acquired immunodeficiency syndrome (AIDS). In: Wallach J, editor. Interpretation of diagnostic tests. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2000: 828Google Scholar
  6. 6.
    Human immunodeficiency virus infection. In: Mims C, Playfair J, Roitt I, et al., editor. Medical microbiology. 2nd ed. Philadelphia (PA): Mosby, 1998: 245–6Google Scholar
  7. 7.
    HIV/AIDS surveillance in Greece. Athens: Hellenic Centre for Infectious Diseases Control, 2001 Jun. HCIDC publications no. 13Google Scholar
  8. 8.
    McKinney RE, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987; 9: 334–56PubMedCrossRefGoogle Scholar
  9. 9.
    Detection of virus and provisional identification. In: Koneman E, Allen S, Janda W, et al., editors. Color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins, 1997: 1238–40Google Scholar
  10. 10.
    Muir P, Kammerer U, Korn K, et al. Molecular typing of enteroviruses: current status and future requirements. Clin Microbiol Rev 1998; 11(1): 202–27PubMedGoogle Scholar
  11. 11.
    Casas I, Powel I, Klapper PE, et al. New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 1995; 53: 25–36PubMedCrossRefGoogle Scholar
  12. 12.
    Georgopoulou A, Markoulatos P, Spyrou N, et al. Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol 2000; 38(12): 4337–42PubMedGoogle Scholar
  13. 13.
    Georgopoulou A, Markoulatos P, Spyrou N, et al. High sequence divergence in the 5′ non-coding region of reference coxsackie B and Echo viral strains and clinical isolates revealed by restriction fragment length polymorphism analysis. Mol Cell Probes 2001; 15: 317–27PubMedCrossRefGoogle Scholar
  14. 14.
    Siafakas N, Markoulatos P, Stanway G. Variability in molecular typing of Coxsackie A viruses by RFLP analysis and sequencing. J Clin Lab Anal 2002; 16: 59–69PubMedCrossRefGoogle Scholar
  15. 15.
    Laboratory diagnosis of enteroviral infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 1611Google Scholar
  16. 16.
    Manual for the virological investigation of poliomyelitis. Geneva: World Health Organization, 1997Google Scholar
  17. 17.
    2002: lowest number of polio infected countries ever-but more cases. Polio News Eradication 2002: 17: 1Google Scholar
  18. 18.
    Poliomyelitis. Fact sheet 04/02. Geneva: World Health Organization, 2002 Jun 21Google Scholar
  19. 19.
    Post-eradication immunization policy for poliomyelitis [online]. WHO/POLIO/ 02.04; updated 2002 Jan. Available from URL: [Accessed 2004 Apr 7]
  20. 20.
    Siafakas N, Georgopoulou A, Markoulatos P, et al. Isolation of polioviruses and other enteroviruses in south Greece between 1994 and 1998. J Clin Lab Anal 2000; 14: 157–63PubMedCrossRefGoogle Scholar
  21. 21.
    Martin J, Dunn G, Hull R, et al. Evolution of the sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 2000; 74(7): 3001–10PubMedCrossRefGoogle Scholar
  22. 22.
    Bellmunt A, May G, Zell R, et al. Evolution of poliovirus type 1 during 5.5 years of prolonged enterai replication in an immunodeficient patient. Virology 1999; 265: 178–84PubMedCrossRefGoogle Scholar
  23. 23.
    Gavrilin G, Cherkasova E, Lipskaya G, et al. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 2000; 74(16): 7381–90PubMedCrossRefGoogle Scholar
  24. 24.
    Kew O, Sutter R, Nottay B, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998; 36(10): 2893–9PubMedGoogle Scholar
  25. 25.
    Dowdle WR, Birmingham ME. The biological principles of poliovirus eradication. J Infect Dis 1997; 175 Suppl. 1: S286–92PubMedCrossRefGoogle Scholar
  26. 26.
    Ryder RW, Octoby MJ, Mvula M, et al. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993; 122: 697–702PubMedCrossRefGoogle Scholar
  27. 27.
    Georgopoulou A, Markoulatos P. Sabin type 2 polioviruses with intertypic vaccine/ vaccine recombinant genomes. Eur J Clin Microbiol Infect Dis 2001; 20: 792–9PubMedCrossRefGoogle Scholar
  28. 28.
    Guillot S, Otelea D, Delpeyroux F, et al. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 2000; 74(18): 8434–43PubMedCrossRefGoogle Scholar
  29. 29.
    Goldschmidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions: 2001. J Am Board Fam Pract 2001; 14: 283–309PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Dimitrios Papaventsis
    • 1
    • 2
    • 3
  • Panayotis Markoulatos
    • 4
    Email author
  • Nikolaos Mangafas
    • 2
  • Marios Lazanas
    • 2
  • Stamatina Levidiotou-Stefanou
    • 3
  1. 1.Department of VirologyHellenic Pasteur InstituteAthensGreece
  2. 2.Infectious Diseases DepartmentRed Cross General HospitalAthensGreece
  3. 3.Microbiology Laboratory, Medical SchoolUniversity of IoanninaIoanninaGreece
  4. 4.Microbiology-Virology Laboratory, Department of Biochemistry and BiotechnologyUniversity of ThessalyLarissaGreece

Personalised recommendations